Author

A. Kervadec

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:deep learning· 2 Organism:Drosophila· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Assay:ChIP-seq· 1

Frequent Co-Authors

A. R. Colas· 2 shared K. Ocorr· 2 shared P. Andersen· 2 shared S. Kannan· 2 shared A. Colas· 1 shared A. Gupta· 1 shared A. Sacco· 1 shared C. Dondi· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

A. R. Colas

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The nutrient sensor CRTC & Sarcalumenin / Thinman represent a new pathway in cardiac hypertrophy

C. Dondi, G. Vogler, A. Gupta, S. M. Walls, A. Kervadec, M. R. Romero, S. B. Diop, J. Goode, J. B. Thomas, A. R. Colas, R. Bodmer, M. Montminy, K. Ocorr

This study identifies CRTC and Sarcalumenin/TMN as a novel conserved pathway involved in cardiac hypertrophy through genetic and functional analyses in Drosophila and zebrafish.

bioRxiv · Oct 2, 2023 · PreprintCell Biology

Multiplatform Modeling of Atrial Fibrillation Identifies Phospholamban as Central Regulator of Cardiac Rhythm

A. Colas, K. Ocorr, E. Grandi, P. Andersen, S. Kannan, S. Spiering, M. Yu, H. Ni, J. Kezos, A. Kervadec

This paper develops a multi-model platform to study atrial fibrillation-associated genes, identifying phospholamban as a key regulator of cardiac rhythm through interactions with calcium handling proteins.

bioRxiv · Sep 23, 2022Pathology

Conserved Transcription Factors Control Chromatin Accessibility and Gene Expression to Maintain Cell Fate Stability and Restrict Reprogramming of Differentiated Cells

M. A. Missinato, S. A. Murphy, M. Lynott, A. Kervadec, M. S. Yu, Y.-L. Chang, S. Kannan, M. Loreti, C. Lee, P. Amatya, H. Tanaka, C.-T. Huang, P. L. Puri, C. Kwon, P. D. Adams, , A. R. Colas

This study identifies four conserved transcription factors that oppose cell fate reprogramming by controlling chromatin accessibility and gene expression, and shows their potential as therapeutic targets for regenerative medicine.

bioRxiv · Jun 28, 2021 · PreprintCell Biology